- Home
- CCEL vs KORE Comparison
CCEL vs KORE Comparison
Compare CCEL & KORE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- KORE
- Stock Information
- Founded
- CCEL 1989
- KORE 2003
- Country
- CCEL United States
- KORE United States
- Employees
- CCEL N/A
- KORE N/A
- Industry
- CCEL Managed Health Care
- KORE Telecommunications Equipment
- Sector
- CCEL Health Care
- KORE Consumer Discretionary
- Exchange
- CCEL Nasdaq
- KORE Nasdaq
- Market Cap
- CCEL 34.8M
- KORE 39.3M
- IPO Year
- CCEL 1997
- KORE N/A
- Fundamental
- Price
- CCEL $4.53
- KORE $2.57
- Analyst Decision
- CCEL Strong Buy
- KORE Hold
- Analyst Count
- CCEL 1
- KORE 2
- Target Price
- CCEL $8.50
- KORE $2.75
- AVG Volume (30 Days)
- CCEL 24.9K
- KORE 19.8K
- Earning Date
- CCEL 10-15-2025
- KORE 11-18-2025
- Dividend Yield
- CCEL 13.22%
- KORE N/A
- EPS Growth
- CCEL N/A
- KORE N/A
- EPS
- CCEL N/A
- KORE N/A
- Revenue
- CCEL $31,988,783.00
- KORE $285,636,000.00
- Revenue This Year
- CCEL $1.75
- KORE $4.46
- Revenue Next Year
- CCEL N/A
- KORE $5.94
- P/E Ratio
- CCEL N/A
- KORE N/A
- Revenue Growth
- CCEL 1.10
- KORE 0.24
- 52 Week Low
- CCEL $4.09
- KORE $1.10
- 52 Week High
- CCEL $9.43
- KORE $4.88
- Technical
- Relative Strength Index (RSI)
- CCEL 45.10
- KORE 59.23
- Support Level
- CCEL $4.51
- KORE $2.39
- Resistance Level
- CCEL $4.93
- KORE $2.76
- Average True Range (ATR)
- CCEL 0.14
- KORE 0.18
- MACD
- CCEL -0.02
- KORE 0.03
- Stochastic Oscillator
- CCEL 36.00
- KORE 66.19
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About KORE KORE Group Holdings Inc.
Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.